There is a shortage of the biosimilar hormonal drug Zyflucort in Russia. According to Kommersant, the drug has disappeared from large pharmacy chains.
The authors of the material point out that the drug disappeared from the shelves of major retailers. The press office of Al-Ragala Pharmacy confirmed to the newspaper that there has been a shortage of the medicine since the beginning of last March, and sales numbers have declined by half compared to the first two months of 2026.
In turn, the manufacturer Pharmasyntez stated that new batches of ZYflucort went on sale on March 2, but they have not yet reached many pharmacies due to increased demand and logistical problems. Rozdravnadzor added that there are about 73,000 packages of the medicine in Russian warehouses, which will soon be sent to retailers.
“Zyflucort” is included in the list of vital medicines. It is also prescribed for Addison’s disease, a rare chronic disease in which the adrenal glands do not produce enough hormones. It explains that the only available analogue – the Polish “Kortineff” – costs almost ten times more and is practically absent from pharmacy chains.Kommersantยป.
Earlier, the media reported that the cost of medicines in Russia increased over the year by an average of 14 percent, which is why Russians began to save on medicines: they buy larger packages and are looking for the cheapest offers through online pharmacy services.
Chairman of the State Duma Committee for Health Protection, Sergei Leonov, explained the categories of Russians who are entitled to receive free medicines. Benefits are divided into federal and regional.